RBI receives FDA approval to proceed with Human Testing (IND 111446) for its AppliGel Polymer Drug Delivery System
FREDERICK, Md.–(BUSINESS WIRE)–Royer Biomedical, Inc. (RBI) received FDA approval to proceed with Human Testing of AppliGel-G (Gentamicin) in management of Diabetic Foot Ulcers (DFU). AppliGel is a patented proprietary dissolvable non-immunogenic Polymer Drug Delivery System Platform. It has demonstrated efficacy in biofilm and infection eradication, without significant systemic API levels. “This represents an important milestone in the development of AppliGel”. […]
